Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study. J of Skin 2023, 7 (2), s109. https://doi.org/10.25251/skin.7.supp.109.